TrialThe European respiratory journal2023

Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one

Cori L Daines et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.